Characterization of clonal dynamics using duplex sequencing in donor-recipient pairs decades after hematopoietic cell transplantation.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
23 Oct 2024
Historique:
medline: 23 10 2024
pubmed: 23 10 2024
entrez: 23 10 2024
Statut: ppublish

Résumé

After allogeneic hematopoietic cell transplantation (HCT), a very small number of donor stem cells reconstitute the recipient hematopoietic system, whereas the donor is left with a near-normal pool of stem cells. We hypothesized that the increased replicative stress on transplanted donor cells in the recipient could lead to the disproportionate proliferation of clonal hematopoiesis (CH) variants. We obtained blood samples from 16 related donor-recipient pairs at a median of 33.8 years (range: 6.6 to 45.7) after HCT, including the longest surviving HCT recipients in the world. For 11 of 16 pairs, a donor sample from the time of HCT was available for comparison. We performed ultrasensitive duplex sequencing of genes recurrently mutated in myeloid malignancies and CH, as well as a set of functionally neutral genomic regions representative of human genomic content at large. CH variants were observed in all donors, even those as young as 12 years old. Where donor pre-HCT sample was available, the average mutation rate in donors compared to recipients post-HCT was similar (2.0% versus 2.6% per year, respectively) within genes recurrently mutated in myeloid malignancies. Twenty-two (5.6%) of the 393 variants shared between paired donors and recipients post-HCT showed ≥10-fold higher variant allele frequency (VAF) in the recipient. A longer time since HCT was positively associated with the expansion of shared variant VAFs in the recipient. In conclusion, even decades after HCT, there does not appear to be widespread accelerated clonal expansion in the transplanted cells, highlighting the immense regenerative capacity of the human hematopoietic system.

Identifiants

pubmed: 39441907
doi: 10.1126/scitranslmed.ado5108
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eado5108

Auteurs

Masumi Ueda Oshima (MU)

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Division of Hematology & Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.

Jacob Higgins (J)

TwinStrand Biosciences, Seattle, WA 98121, USA.

Isaac Jenkins (I)

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.

Timothy Randolph (T)

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.

Thomas Smith (T)

TwinStrand Biosciences, Seattle, WA 98121, USA.

Charles Valentine (C)

TwinStrand Biosciences, Seattle, WA 98121, USA.

Jesse Salk (J)

Division of Hematology & Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.
TwinStrand Biosciences, Seattle, WA 98121, USA.

Cecilia Yeung (C)

Department of Pathology, University of Washington School of Medicine, Seattle, WA 98195, USA.
Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.

Lan Beppu (L)

Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.

Judy Campbell (J)

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.

Paul A Carpenter (PA)

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195, USA.

Stephanie J Lee (SJ)

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Division of Hematology & Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.

Mary E Flowers (ME)

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Division of Hematology & Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.

Jerald P Radich (JP)

Division of Hematology & Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.
Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.

Rainer Storb (R)

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Division of Hematology & Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH